Modification of lung region flow dynamics using flow control devices implanted in bronchial wall channels

• US 20050066974A1
• Filed: 05/28/2003
• Published: 03/31/2005
• Est. Priority Date: 05/28/2002
• Status: Abandoned Application

• Current Assignee: Pulmonx Pulmonx
• Original Assignee: Pulmonx Pulmonx
• Inventors: Hendricksen, Michael, Hundertmark, Ronald, Fields, Antony
• Application Number:
  US10/448,153
• Publication Number:
  US 20050066974A1
• Time in Patent Office: Days
• US Class Current: 128/207.140
• CPC Class Codes: A61F 2/04 Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts A61F2/18, A61F2/20 take precedence; devices, other than stent-grafts, providing patency to, or preventing collapsing of, tubular structures of the body other than stent-grafts, e.g. stents A61F2/82; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95
• CPC Class Codes: A61F 2/06 Blood vessels
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/2427 Devices for manipulating or deploying heart valves during implantation
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2002/043 Bronchi

Abstract

A desired fluid flow dynamic to a lung region can be achieved by deploying various combinations of flow control devices and bronchial isolation devices in one or more bronchial passageways that communicate with the lung region. The flow control devices are implanted in channels that are formed in the walls of bronchial passageways of the lung. The flow control devices regulate fluid flow through the channels. The bronchial isolation devices are implanted in lumens of bronchial passageways that communicate with the lung region in order to regulate fluid flow to and from the lung region through the bronchial passageways.

Claims

1. A flow control device for placement in a bronchial wall of a bronchial passageway in a patient'"'"'s lung, the bronchial wall having inner and outer surfaces, the flow control device comprising:

a tubular body having first and second ends and a passage therethrough, the tubular body being configured to extend through the bronchial wall with the passage in communication with the bronchial passageway;

a first flange on the first end configured to engage an inner surface of the bronchial wall;

a retainer coupled to the tubular body for retaining the tubular body in the bronchial wall; and

a valve in fluid communication with the passage, the valve configured to allow fluid flow through the passage in a first direction and restrict fluid flow through the passage in a second direction.

2. The flow control device of claim 1, wherein the retainer comprises a second flange on the second end of the tubular body configured to engage an outer surface of the bronchial wall.

3. The flow control device of claim 1, wherein the retainer comprises an expandable stent coupled to the tubular body.

4. The flow control device of claim 3, wherein the expandable stent is resiliently self-expanding.

5. The flow control device of claim 1, further comprising a seal for limiting fluid flow through the bronchial wall exterior to the passage.

6. The flow control device of claim 5, wherein the seal is disposed on the first flange or the second flange.

7. The flow control device of claim 5, wherein the seal is disposed on an exterior surface of the tubular body.

8. The flow control device of claim 7, wherein the seal is integrally formed with the tubular body.

9. The flow control device of claim 7, wherein the seal is urged into engagement with the bronchial wall by the tubular body.

10. The flow control device of claim 5, wherein the seal is urged into engagement with the bronchial wall by the retainer.

11. The flow control device of claim 1, wherein the valve comprises at least one leaflet movable to an open position in response to fluid flow in the first direction and movable to a closed position in response to fluid flow in the second direction.

12. The flow control device of claim 11, wherein the valve is a duckbill valve.

14. The flow control device of claim 11, wherein the valve is a flap valve.

15. The flow control device of claim 1, wherein the valve is integrally formed with the tubular body.

16. The flow control device of claim 1, wherein the proximal flange is integrally formed with the tubular body.

17. A method of modifying fluid flow through a channel in communication with a bronchial passageway in a patient'"'"'s lung, the bronchial passageway having a wall through which the channel extends, the wall having inner and outer surfaces, the method comprising:

positioning a flow control device in the bronchial passageway, the flow control device having first and second ends and a passage therebetween;

inserting the first end of the flow control device through the channel in the wall so that the passage is in communication with the bronchial passageway;

securing the flow control device in the wall;

allowing fluid flow in a first direction through the passage to or from the bronchial passageway; and

restricting fluid flow in a second direction through the passage to or from the bronchial passageway.

18. The method of claim 17, further comprising providing a seal between the flow control device and the wall to restrict fluid flow therebetween.

19. The method of claim 18, wherein the seal is provided by a flange on the flow control device that engages the inner surface of the wall.

20. The method of claim 18, wherein securing the flow control device comprises expanding a stent on the flow control device into engagement with the wall.

21. The method of claim 20, wherein restricting fluid flow in a second direction through the passage comprises moving a portion of a valve on the flow control device to at least partially occlude the passage.

22. The method of claim 17, wherein the first direction is toward the bronchial passageway from the passage in the flow control device.

23. A method of treating a target region of a patient'"'"'s lung comprising:

deploying at least one bronchial isolation device in a bronchial passageway of the target region, wherein the bronchial isolation device allows flow in an expiration direction and restricts flow in an inspiration direction through the bronchial passageway; and

forming at least one channel that extends through a wall of a bronchial passageway of the target region, wherein the channel provides a fluid passageway between a location internal to the bronchial passageway and a location external to the bronchial passageway.

24. A method as defined in claim 23, wherein the location external to the bronchial passageway comprises the lung parenchyma.

25. A method as defined in claim 23, further comprising deploying a flow control device in the channel, wherein the flow control device allows fluid flow in a first direction through the channel and restricts fluid flow in a second direction through the channel.

26. A method as defined in claim 23, wherein the channel is distal to the location of the bronchial isolation device.

27. A method as defined in claim 23, wherein the channel is proximal to the location of the bronchial isolation device.

28. A method as defined in claim 23, wherein the channel extends through a wall of the same bronchial passageway in which the bronchial isolation device is deployed.